Kathleen Chiotos
-
- Antibiotic Use and Resistance 18
- Molecular Medicine top 2%
-
- Nosocomial Infections in ICU 9
- Family Practice top 10%
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 7
-
- Kawasaki Disease and Coronary Complications 13
-
- Sepsis Diagnosis and Treatment 11
- Pneumonia and Respiratory Infections 8
-
- Antibiotics Pharmacokinetics and Efficacy 11
-
- Bacterial Identification and Susceptibility Testing 10
- Co-authors
- Pranita D. TammaJeffrey S. GerberJulie C. FitzgeraldAudrey R. Odom JohnCaroline DiorioHamid BassiriEdward M. BehrensJennifer Han
- Cited by
- Applied Microbiology and BiotechnologyMolecular MedicineCritical Care and Intensive Care Medicine
- Journals
- JAMA (1 paper)SHILAP Revista de lepidopterología (1 paper)Neurology (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Kathleen Chiotos
60 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 88
- Applied Microbiology and Biotechnology 159
- Molecular Medicine 220
- Critical Care and Intensive Care Medicine 105
- Family Practice 37
- Infectious Diseases 296
Countries citing papers authored by Kathleen Chiotos
This map shows the geographic impact of Kathleen Chiotos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Chiotos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Chiotos more than expected).
Fields of papers citing papers by Kathleen Chiotos
This network shows the impact of papers produced by Kathleen Chiotos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Chiotos. The network helps show where Kathleen Chiotos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kathleen Chiotos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 20 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 12 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 44 | |
| 13 | 2021 | 9 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2019 | 19 | |
| 17 | 2019 | 6 | |
| 18 | 2016 | 39 | |
| 19 | 2016 | 3 | |
| 20 | 2008 | 17 |
About Kathleen Chiotos
Kathleen Chiotos is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine and Clinical Biochemistry, having authored 65 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (18 papers), Kawasaki Disease and Coronary Complications (13 papers), Sepsis Diagnosis and Treatment (11 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), Bacterial Identification and Susceptibility Testing (10 papers), Nosocomial Infections in ICU (9 papers), Pneumonia and Respiratory Infections (8 papers) and COVID-19 Clinical Research Studies (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (159 citations), Molecular Medicine (220 citations) and Critical Care and Intensive Care Medicine (105 citations). Kathleen Chiotos has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Pranita D. Tamma, Jeffrey S. Gerber, Julie C. Fitzgerald, Audrey R. Odom John, Caroline Diorio, Hamid Bassiri, Edward M. Behrens, Jennifer Han, Joyce C. Chang and Allison M. Blatz. Their work appears in journals such as JAMA, SHILAP Revista de lepidopterología and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.